Frontiers | Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways
Structures of gemcitabine and ara-C (cytarabine). | Download High-Resolution Scientific Diagram
Sea to Ara C: Part 5
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Subcut Cytarabine (Ara-C) Shared Care and Community
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
Marine Drugs | Free Full-Text | Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery | HTML
AraC Protein - an overview | ScienceDirect Topics
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
AraC-like transcriptional activator CuxR binds c-di-GMP by a PilZ-like mechanism to regulate extracellular polysaccharide production | PNAS
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes | Haematologica
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia - Nanoscale (RSC Publishing)
Cytarabine (cytosine Arabinoside, Ara-c) Chemotherapy Drug Molecule. Used In Treatment Of Acute Myeloid Leukemia (aml), Acute Lymphocytic Leukemia (all) And Lymphoma. Skeletal Formula. Stock Photo, Picture And Royalty Free Image. Image 93261187.